|
OMNIPAQUE 240
|
6505-01-226-5518
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
Y-203
|
6505-01-226-5518
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00407-1412-10
|
6505-01-226-5518
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-1412-10
|
6505-01-226-5518
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
OMNIPAQUE 300
|
6505-01-226-6499
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
Y-352
|
6505-01-226-6499
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
6-0375
|
6505-01-226-6499
|
Usp Iohexol Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00407-1413-51
|
6505-01-226-6499
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
OMNIPAQUE 300
|
6505-01-226-6501
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
Y-306
|
6505-01-226-6501
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00407-1413-10
|
6505-01-226-6501
|
Usp Iohexol Injection |
Ge Healthcare Inc.
|
|
Quote
|
|
NDC00407-1413-10
|
6505-01-226-6501
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
RVG09820
|
6505-01-226-6501
|
Usp Iohexol Injection |
Ministerie Van
|
|
Quote
|
|
1637944
|
6505-01-226-6501
|
Usp Iohexol Injection |
Alliance Healthcare Nederland B.v.
|
|
Quote
|
|
ZI13661434
|
6505-01-226-6501
|
Usp Iohexol Injection |
Nycomed Nederland B.v.
|
|
Quote
|
|
26170035
|
6505-01-226-6501
|
Usp Iohexol Injection |
Ge Healthcare Clinical Systems B.v.
|
|
Quote
|
|
26170035
|
6505-01-226-6501
|
Usp Iohexol Injection |
Nycomed Nederland B.v.
|
|
Quote
|
|
NDC00024-1413-10
|
6505-01-226-6501
|
Usp Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00071-0100-40
|
6505-01-226-6541
|
Chlorpromazine Hydrochloride Tab |
Parke-davis
|
|
Quote
|
|
NDC47679-0144-35
|
6505-01-226-7355
|
Triprolidine And Pseudoephedrine |
Baxter Healthcare Corp
|
|
Quote
|
|
XYLOCAINE
|
6505-01-226-8048
|
Lidocaine Hydrochloride Injectio |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
XYLOCAINE INJECTION
|
6505-01-226-8048
|
Lidocaine Hydrochloride Injectio |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00186-0232-03
|
6505-01-226-8048
|
Lidocaine Hydrochloride Injectio |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC12280-0046-04
|
6505-01-226-8050
|
Ascorbic Acid Syrup |
Pharmaceutical Basics Inc
|
|
Quote
|
|
ISORDIL TITRADOSE E-Z SPLIT
|
6505-01-226-9796
|
Mod Isosorbide Dinitrate Tablets |
Ives Laboratories Inc
|
|
Quote
|
|
NDC00082-4159-03
|
6505-01-226-9796
|
Mod Isosorbide Dinitrate Tablets |
Ives Laboratories Inc
|
|
Quote
|
|
RIDAURA
|
6505-01-226-9907
|
Auranofin Capsules |
Prometheus Laboratories Inc.
|
|
Quote
|
|
65483009306
|
6505-01-226-9907
|
Auranofin Capsules |
Prometheus Laboratories Inc.
|
|
Quote
|
|
NDC65483-0093-06
|
6505-01-226-9907
|
Auranofin Capsules |
Prometheus Laboratories Inc.
|
|
Quote
|
|
MINTEZOL TABLETS
|
6505-01-226-9909
|
Usp Thiabendazole Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
MINTEZOL
|
6505-01-226-9909
|
Usp Thiabendazole Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-0907-36
|
6505-01-226-9909
|
Usp Thiabendazole Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-0907-36
|
6505-01-226-9909
|
Usp Thiabendazole Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
MIN121
|
6505-01-226-9909
|
Usp Thiabendazole Tablets |
Idis
|
|
Quote
|
|
SANI SUPP
|
6505-01-226-9917
|
Usp Glycerin Suppositories |
G & W Laboratories, Inc.
|
|
Quote
|
|
NDC00713-0102-25
|
6505-01-226-9917
|
Usp Glycerin Suppositories |
G & W Laboratories, Inc.
|
|
Quote
|
|
BETOPIC
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BETOPIC DROP-TAINER
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC60505-0556-03
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC00065-0245-10
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BETOPIC
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BETOPIC DROP-TAINER
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC60505-0556-03
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC00065-0245-10
|
6505-01-227-1545
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ONCOVIN HYPORET
|
6505-01-227-1608
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
7198 HYPORET
|
6505-01-227-1608
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-7198-09
|
6505-01-227-1608
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
ONCOVIN HYPORET
|
6505-01-227-1608
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
7198 HYPORET
|
6505-01-227-1608
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-7198-09
|
6505-01-227-1608
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
ONCOVIN
|
6505-01-227-1609
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-7199-09
|
6505-01-227-1609
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
ONCOVIN
|
6505-01-227-1609
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-7199-09
|
6505-01-227-1609
|
Us Vincristine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00574-0430-25
|
6505-01-227-3559
|
Usp Progesterone |
Paddock Laboratories Inc.
|
|
Quote
|
|
FORTAZ
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
TAZIDIME
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00173-0378-35
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00002-7231-25
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Eli Lilly and Company
|
|
Quote
|
|
FORTAZ
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
TAZIDIME
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00173-0378-35
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00002-7231-25
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Eli Lilly and Company
|
|
Quote
|
|
TAZICEF
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-5082-16
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Hospira, Inc.
|
|
Quote
|
|
NDC25021-0127-20
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Sagent Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC44567-0235-25
|
6505-01-227-3570
|
Usp Ceftazidime For Injection |
Wg Critical Care, Llc
|
|
Quote
|
|
AMVISC
|
6505-01-227-3598
|
Sodium Hyaluronate Injection |
Precision Cosmet Co Inc
|
|
Quote
|
|
5908
|
6505-01-227-3598
|
Sodium Hyaluronate Injection |
Precision Cosmet Co Inc
|
|
Quote
|
|
AMVISC
|
6505-01-227-3598
|
Sodium Hyaluronate Injection |
Precision Cosmet Co Inc
|
|
Quote
|
|
5908
|
6505-01-227-3598
|
Sodium Hyaluronate Injection |
Precision Cosmet Co Inc
|
|
Quote
|
|
MVI 12 LYOPHILIZED
|
6505-01-227-5004
|
Multivitamin For Injection |
Armour Pharmaceutical Co
|
|
Quote
|
|
1829-35RX
|
6505-01-227-5004
|
Multivitamin For Injection |
Armour Pharmaceutical Co
|
|
Quote
|
|
NDC00053-1829-35
|
6505-01-227-5004
|
Multivitamin For Injection |
Armour Pharmaceutical Co
|
|
Quote
|
|
MVI 12 LYOPHILIZED
|
6505-01-227-5004
|
Multivitamin For Injection |
Armour Pharmaceutical Co
|
|
Quote
|
|
1829-35RX
|
6505-01-227-5004
|
Multivitamin For Injection |
Armour Pharmaceutical Co
|
|
Quote
|
|
NDC00053-1829-35
|
6505-01-227-5004
|
Multivitamin For Injection |
Armour Pharmaceutical Co
|
|
Quote
|
|
NDC00173-0748-35
|
6505-01-227-5007
|
Neomycin And Polymyxin B Sulfate |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0748-35
|
6505-01-227-5007
|
Neomycin And Polymyxin B Sulfate |
Glaxo Wellcome Inc
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
GENAPAP CHILDRENS' CHEWABLE TABS
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1585-17
|
6505-01-227-5554
|
Usp Acetaminophen Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
SPARINE
|
6505-01-227-6721
|
Promazine Hydrochloride Tablets |
American Home Products Corp
|
|
Quote
|
|
NDC00008-0200-01
|
6505-01-227-6721
|
Promazine Hydrochloride Tablets |
American Home Products Corp
|
|
Quote
|
|
NDC00008-0200-01
|
6505-01-227-6721
|
Promazine Hydrochloride Tablets |
American Home Products Corp
|
|
Quote
|
|
SPARINE
|
6505-01-227-6721
|
Promazine Hydrochloride Tablets |
American Home Products Corp
|
|
Quote
|
|
NDC00409-7337-01
|
6505-01-227-7028
|
Usp Ceftriaxone Sodium |
Hospira, Inc.
|
|
Quote
|
|
NDC00731-3206-95
|
6505-01-227-7028
|
Usp Ceftriaxone Sodium |
Sandoz Inc.
|
|
Quote
|
|
NDC00781-3206-95
|
6505-01-227-7028
|
Usp Ceftriaxone Sodium |
Sandoz Inc.
|
|
Quote
|
|
NDC00409-7337-01
|
6505-01-227-7028
|
Usp Ceftriaxone Sodium |
Hospira, Inc.
|
|
Quote
|
|
NDC00781-3206-95
|
6505-01-227-7028
|
Usp Ceftriaxone Sodium |
Sandoz Inc.
|
|
Quote
|
|
NDC00071-2195-20
|
6505-01-227-7332
|
Diphenhydramine Hydrochloride Sy |
Parke-davis
|
|
Quote
|
|
NDC00071-2195-20
|
6505-01-227-7332
|
Diphenhydramine Hydrochloride Sy |
Parke-davis
|
|
Quote
|
|
NDC00045-0508-40
|
6505-01-227-7993
|
Acetaminophen And Codeine Phosph |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
TAZIDIME
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Eli Lilly and Company
|
|
Quote
|
|
TAZICEF
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
FORTAZ
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0379-34
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00002-7234-10
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00007-5084-11
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
K5084-11
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC24987-0379-34
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Covis Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC00409-5084-11
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Hospira, Inc.
|
|
Quote
|
|
NDC00781-3178-95
|
6505-01-228-0009
|
Usp Ceftazidime For Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
